title: Does the angiotensin-converting enzyme (ACE)/ACE2 balance contribute to the fate of angiotensin peptides in programmed hypertension?
authors.forename: K Bridget
authors.initials: KB
authors.lastname: Brosnihan
authors.forename: Liomar A A
authors.initials: LA
authors.lastname: Neves
authors.forename: Mark C
authors.initials: MC
authors.lastname: Chappell
mesh_terms: D000085962:Angiotensin-Converting Enzyme 2; D000809:Angiotensins / Q000378:metabolism*; D000818:Animals; D002268:Carboxypeptidases / Q000378:metabolism*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000209:etiology* / Q000378:metabolism*; D010446:Peptide Fragments / Q000378:metabolism; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D039401:Prenatal Nutritional Physiological Phenomena
chemical_list: D000809:Angiotensins; D010446:Peptide Fragments; D002268:Carboxypeptidases; D007703:Peptidyl-Dipeptidase A; C000705307:ACE2 protein, human; D000085962:Angiotensin-Converting Enzyme 2